Latest from The Oncologist

The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.

March 8, 2021
Metastatic Myxofibrosarcoma with Durable Response to Temozolomide Followed by Atezolizumab: A Case Report

The Oncologist, EarlyView.

March 8, 2021
Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two‐Cohort, Phase Ib/II Trial

The Oncologist, EarlyView.

March 6, 2021
Optimizing Regorafenib Dosing and Patient Management in Colorectal Cancer in Latin America: Perspectives from Argentina

The Oncologist, EarlyView.

March 6, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial

The Oncologist, EarlyView.

March 6, 2021
Implementing Historical Controls in Oncology Trials

The Oncologist, EarlyView.